Harm Reduction Services
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).
Eligibility criteria
Qualifiers
at least 18 years of age
self-identified as misusing opioids +/- other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria
English or Spanish speaking
able to provide informed consent.
Disqualifiers
inability to provide informed consent or participate in the study procedures as proposed in the consent
active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder)
an unwillingness to be randomized.
are prisoners
Trial design
Treatments tested in this trial
- Integrated Harm Reduction Intervention (IHRI)
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
NYU Langone Health
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator
Source ClinicalTrials.gov